- Research Article
- 10.1016/j.jinorgbio.2025.113154
Dehalogenation activity of a miniaturized peroxidase: substrate dependent functional switch.
- Mar 01, 2026
- Journal of inorganic biochemistry
- Maria De Fenza + 8 more +8
Publications from 2021 to 2026
Showing 10 of 464 papers
Dehalogenation activity of a miniaturized peroxidase: substrate dependent functional switch.
Synthesis and application of hydrochar from artichoke as an innovative product to increase soil fertility and act as plant biostimulant
Ga-68-Edotreotide PET/CT SSTR Total Tumor Volume as a Predictor of Outcome in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors
IntroductionThe somatostatin receptor (SSTR) standardized uptake value (SUVmaxsstr) obtained by [68Ga]Ga-edotreotide positron emission tomography-computed tomography ([68Ga]Ga-SSTR PET/CT) helps recognize patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) who are at a high risk for adverse outcomes. This observational cohort study was conducted to verify whether the SSTR representative tumor volume (RTVsstr) can provide incremental prognostic information over conventional PET/CT parameters in patients with metastatic disease.MethodsWe retrospectively evaluated patients (48% female) with metastatic GEP-NETs who underwent [68Ga]Ga-SSTR PET/CT between January 2022 and November 2023. The mean SUVmaxsstr, mean RTVsstr (cm3; 42% threshold), and total RTVsstr were recorded. Thereafter, patients were followed up for 22.9 (range: 8-42) months. The PET/CT results were compared to the progression free survival (PFS).ResultsSixty patients (59 ± 5 years) were enrolled. Only the mean and total RTVsstr values were predictive in the multivariate analysis. Kaplan-Meier survival analysis for both the mean and total RTVsstr demonstrated a significantly better PFS in patients presenting with lower than greater values (P = 0.001 and P = 0.007, respectively; log-rank test). SUVmaxsstr was not appropriate for predicting PFS.ConclusionThe mean or total RTVsstr represents a valuable volumetric parameter able to predict outcomes in patients with GEP-NETs that are metastatic at onset. The degree of the SSTR representative tumor burden, rather than the maximal SSTR representation at single voxel, has a predominant value for influencing the response to therapy in this cohort.
Read moreGeorgian Grapes and Wines as a Source of Phenolic Compounds: Composition, Antioxidant Activity, and Traditional Winemaking †
Georgia is recognized as one of the world’s earliest known centers of grape cultivation and wine production, as well as the home of 525 indigenous grape varieties. Phenolic compounds are a diverse group of secondary metabolites which are present in both grapes and wine, with the phenolic derivatives determining the organoleptic properties and the antioxidant activity of the resulting wines. Remarkably, the content and composition of phenolic compounds in wine are mainly influenced by the grape variety and the winemaking method. In this context, herein we review the present knowledge on the phenolic composition of the most common Georgian grape varieties and discuss available molecular insights on the resulting wines. The comparison of traditional European and traditional Georgian “qvevri” winemaking methods revealed that this method provides high antioxidant activity of Georgian wines, as well as a unique phenolic composition of red and white Georgian wines.
Read moreNon-invasive staging of hepatic steatosis by Quantification Attenuation Index (QAI).
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition that can progress to cirrhosis and hepatocellular carcinoma. Non-invasive techniques are increasingly used to assess hepatic steatosis. This study aimed to evaluate the accuracy of the Quantification Attenuation Index (QAI) and define diagnostic cut-offs by comparing QAI to liver biopsy and controlled attenuation parameter (CAP). This prospective study included adults with chronic liver disease undergoing B-mode ultrasound, QAI, and vibration-controlled transient elastography with CAP. Liver biopsy, performed when indicated, served as gold standard. Diagnostic performance was assessed by ROC analysis; agreement between QAI and CAP was assessed using Cohen's kappa. A total of 209 patients were included (median age 62 years; 57.4% male). MASLD was diagnosed in 63 patients, who showed significantly higher CAP (288 dB/m) and QAI (0.88 dB/cm/MHz) compared to other liver diseases (CAP 235 dB/m; QAI 0.70 dB/cm/MHz; P<0.001). Steatosis was histologically confirmed in 22/40 biopsied patients. ROC analysis using biopsy as reference identified a QAI cut-off of 0.67 dB/cm/MHz for distinguishing absence of steatosis (S0) from any degree of steatosis (≥S1) (AUROC 0.683; sensitivity 63%, specificity 73%) and a cut-off of 0.81 dB/cm/MHz for discriminating severe steatosis (S3) from lower grades (≤S2) (AUROC 0.925; sensitivity 100%, specificity 87%). The overall agreement between QAI and CAP was substantial (κ=0.767 and κ=0.734; P<0.001). QAI correlated better with biopsy (r=0.719, P<0.001) than CAP (r=0.540, P<0.001). QAI is a reliable, non-invasive method for assessing hepatic steatosis, with good agreement with histology and with CAP.
Read moreElevated Epithelial Splicing Regulatory Protein 1 Expression in Biliary Atresia Indicates Its Potential as a Molecular Marker.
Cholangiopathies encompass a wide range of chronic liver diseases that target biliary epithelial cells, leading to significant morbidity and mortality due to their progressive nature, limited treatment options, and complex clinical management. Currently, clinically validated biomarkers capable of distinguishing obstructive cholangiopathies, such as biliary atresia (BA), from other cholangiopathies are lacking, hindering timely intervention. RNA-binding proteins (RBPs) have been increasingly linked to human diseases but their roles in cholangiopathies remain underexplored. We assessed the expression of the RBP epithelial splicing regulatory protein 1 (ESRP1) in murine models of cholangiopathies and in the human system. Our findings demonstrate that ESRP1 is highly and specifically expressed in cholestatic liver injury models, including bile duct-ligated, diethoxycarboncyl-1,4-dihydrocollidine-treated, and Mdr2-/- mice when compared with other liver injury models. Importantly, ESRP1 is markedly elevated in the livers of patients with BA and cystic fibrosis-related liver disease, localizing to cholangiocytes and peri-biliary hepatic cells, but is minimal in primary sclerosing cholangitis and primary biliary cholangitis. Moreover, patient-derived BA organoids and biliatresone-treated healthy organoids also display ESRP1 expression. Bioinformatics analysis further implicates ESRP1 in key cholangiopathy-associated pathways, warranting deeper mechanistic investigation. Thus, ESRP1 holds potential as a molecular marker for obstructive cholangiopathies, warranting further mechanistic studies.
Read moreEfficacy of nutraceutical supplements containing Passiflora incarnata L., Withania somnifera (L.) Dunal and Taraxacum officinale (L.) weber ex F.H.Wigg. on markers of inflammation, oxidative stress and gut microbiota in senior dogs
IntroductionAging in dogs is a complex phenomenon characterized by metabolic, immunological and neurological alterations that may result in chronic inflammation, oxidative stress, and intestinal microbiota changing that can compromise dogs’ overall health. Phytotherapeutics represents a promising approach to improve the quality of life in elderly dogs. In this study we have tested a mix of phytoextracts on seven old breed dogs to evaluate their synergistic beneficial effects.MethodsThe mix was constituted by Passiflora incarnata (4% vitexin), Withania somnifera (2.5% withanolides), and Taraxacum officinale (20% inulin) administered per os for 40 days in addition to their diet. The whole blood and serum have been collected at the beginning of the experimental phase (T0), after 20 days (T1) and at the end point of the experiment, i.e., 40 days (T2), and used for biochemical analysis, detection of interleukins by ELISA, and for malondialdehyde (MDA) and Total antioxidant capacity (TAC) assay. Fresh feces have been collected at the same time points and immediately frozen to evaluate gut microbiota modification by 16S rRNA sequencing.ResultsResults revealed a significant reduction of C-reactive protein (CRP) for T1 and T2 respect to the basal condition (T0) (p < 0.05). Moreover, a statistical decrease in IL-6 and IL-10 cytokines at both T1 and T2 was observed, probably due to mitigation of chronic inflammation in the treated old dogs. The addition of the abovementioned extracts into the diet was associated with TAC increase and reduced lipid peroxidation in the sera of aged dogs, especially at T2 (p < 0.01). After treatment, an interesting modulation of the microbiota was observed with a trend from T0 to T2 toward higher relative abundances of SCFA-producing taxa, although alpha and beta diversity metrics did not reach statistical significance.DiscussionThis study supports the hypothesis that the integration of these herbal medicines into dietary or therapeutic regimens could represent a natural and synergistic strategy to improve the quality of life, promoting the general well-being of old dogs.
Read moreSelection of short Gadd45β‐binding peptides through a synergistic computational and biophysical approach
In this study, we explored the design of linear D‐tripeptides tailored to bind specific cavities of Gadd45β, chosen as a model protein target. To identify peptides that selectively interact with predicted binding sites, we combined computational modeling with biophysical experiments. Gadd45β was selected since it has emerged as a promising therapeutic target involved in multiple disease pathways, including cancer and inflammation. Computational analysis was first employed to characterize the structural features and potential binding sites of Gadd45β. Guided by these insights, linear D‐tripeptides were designed and optimized for specific interactions with the target surface. The resulting candidates were subsequently assessed through a series of biophysical assays to evaluate their binding affinity, selectivity, and potential therapeutic activity. Complementary computational simulations were employed to gain atomistic insight into the dynamics of peptide–protein recognition. This integrated computational–experimental strategy led to the identification of two D‐tripeptides, RYR and VWR, that bind Gadd45β at a biologically relevant site, illustrating a general framework for early‐stage peptide ligand discovery.
Read moreGlioblastoma resistance to EGFR antibody-drug conjugate is driven by transcriptional reprogramming and TEK-induced EGFR suppression
BackgroundGlioblastoma (GBM), the most common primary malignant brain tumor in adults, remains uniformly fatal due to the lack of effective targeted therapies. The epidermal growth factor receptor (EGFR) is the most frequently altered receptor tyrosine kinase oncogene in GBM with most alterations impacting the receptor ectodomain function, including gene amplification, mutation, rearrangement, and splicing site changes, which occur in approximately 50% of GBM tumors. Depatuxizumab mafodotin (Depatux-M; ABT-414), an antibody-drug conjugate composed of an EGFR-specific antibody (ABT-806) that recognizes the EGFR ectodomain linked to the cytotoxic agent monomethyl auristatin F, initially showed clinical promise. However, it failed to improve survival in phase III trials, highlighting an urgent need to understand mechanisms of resistance.MethodsWe generated in vivo ABT-414 resistant GBM models using patient-derived xenografts (PDXs) and performed genomics and transcriptomic profiling, including whole exome sequencing, bulk RNA sequencing, and single-cell RNA sequencing.ResultsABT-414-resistant tumors exhibited transcriptional reprogramming characterized by upregulation of synaptic and developmental gene networks and downregulation of biosynthetic processes, indicative of a plastic, therapy-adaptive state. Whole-exome sequencing revealed novel mutations exclusive to resistant tumors, including a recurrent TEK (TIE2) S466I point mutation present in all ABT-414 resistant GBM12 PDX tumors. Functional validation demonstrated that ectopic expression of TEK S466I and TEK WT in PDX models reduced EGFR levels, suggesting a novel feedback mechanism linking TEK signaling to EGFR downregulation and contributes to resistance.ConclusionOur findings demonstrate that resistance to ABT-414 arises through both adaptive transcriptional remodeling and newly acquired genetic alterations. TEK-mediated suppression of EGFR represents a previously unrecognized mechanism of resistance, with potential implications for overcoming antibody-drug conjugate failure in GBM.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12967-025-07216-5.
Read more2782P Evaluation of TROP2 for immunotherapy response in SCLC along with expression of STING related biomarkers in CTCs